Liz Bhatt, MS, MBA, is the Chief Operating Officer at Septerna. Ms. Bhatt has more than 30 years of strategy, deal-making and company-building experience across a range of biotech and pharmaceutical companies.
Ms. Bhatt was previously Chief Business & Strategy Officer at Applied Molecular Transport (AMT), where she oversaw corporate development, portfolio and project management, and commercial strategy. Prior to AMT, she was Chief Business Officer and later also Chief Operating Officer at Achaogen, where she led corporate development, alliance management and government affairs. Prior to Achaogen, she spent over a decade at Gilead Sciences as VP, Corporate Development, leading deals across all therapeutic areas. Ms. Bhatt also led long-term global commercial and strategic planning for Gilead’s antiviral and respiratory franchises and supported the launch of several products. Earlier in her career, Ms. Bhatt held numerous corporate development positions across a range of biotech and pharmaceutical companies, including Eli Lilly and Maxygen.
Ms. Bhatt earned a BA in Chemistry from Pomona College, an MS in Biomedical Sciences from the University of California San Diego, and an MBA from the Kellogg School of Management at Northwestern University.